Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.
Saved in:
| Title: | Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes. |
|---|---|
| Authors: | Post Z; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA., Maniak A; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA., DeMeo A; Rush University, Rush Medical College, Chicago, Illinois, USA., Keshavarzian A; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA.; Rush Center for Integrated Microbiome and Chronobiology Research (CIMCR), Rush University Medical Center, Chicago, Illinois, USA.; Departments of Physiology and Anatomy & Cell Biology, Rush University, Chicago, Illinois, USA. |
| Source: | Chronobiology international [Chronobiol Int] 2026 Mar; Vol. 43 (3), pp. 328-338. Date of Electronic Publication: 2025 Dec 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8501362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6073 (Electronic) Linking ISSN: 07420528 NLM ISO Abbreviation: Chronobiol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1525-6073 |
|---|---|
| DOI: | 10.1080/07420528.2025.2599354 |
